Jmac Enterprises LLC Baxter International Inc Transaction History

Jmac Enterprises LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	SELL	$39.98 - $47.68 $188,145 - $224,382	-4,706 Reduced 45.24%	5,696 $259,000
Q1 2023 Apr 20, 2023	SELL	$37.58 - $52.57 $46,862 - $65,554	-1,247 Reduced 10.7%	10,402 $421,000
Q4 2022 Jan 23, 2023	SELL	$49.7 - $57.71 $124,349 - $144,390	-2,502 Reduced 17.68%	11,649 $0
Q3 2022 Oct 20, 2022	BUY	$53.86 - $66.8 $23,698 - $29,392	440 Added 3.21%	14,151 $762,000
Q2 2022 Jul 25, 2022	BUY	$63.83 - $80.0 $5,936 - $7,440	93 Added 0.68%	13,711 $881,000
Q1 2022 May 16, 2022	BUY	$76.85 - $89.45 $4,073 - $4,740	53 Added 0.39%	13,618 $1.06 Million
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $1.01 Million - $1.18 Million	13,565 New	13,565 $1.19 Million

996

449M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Jmac Enterprises LLC, based on Form 13F filings with the SEC.

Stay updated on Jmac Enterprises LLC with notifications on news.